Giordana Maria Teresa, D'Agostino Carla, Albani Giovanni, Mauro Alessandro, Di Fonzo Alessio, Antonini Angelo, Bonifati Vincenzo
Department of Neuroscience, University of Torino, Torino, Italy.
Mov Disord. 2007 Jan 15;22(2):275-8. doi: 10.1002/mds.21281.
Leucine-Rich Repeat Kinase 2 (LRRK2) gene mutations are the most common known cause of Parkinson's disease (PD), but neuropathological studies are available on very few patients with LRRK2 mutation. The reported findings range from Lewy body-positive pathology to different pathologies, including nigral degeneration without distinctive features, neuronal loss with only ubiquitin-positive inclusions, and tau-positive-only pathology. Here we report the first neuropathological study in an Italian PD case carrying a different LRRK2 mutation, Ile1371Val, and showing typical ubiquitin- and alpha-synuclein-positive Lewy body pathology. These findings support the concept that the neurodegeneration associated with LRRK2 mutations might be clinically and pathologically indistinguishable from typical PD.
富含亮氨酸重复激酶2(LRRK2)基因突变是已知帕金森病(PD)最常见的病因,但对携带LRRK2突变的患者进行神经病理学研究的病例却非常少。报告的研究结果涵盖从路易体阳性病理到不同的病理情况,包括无明显特征的黑质变性、仅伴有泛素阳性包涵体的神经元丢失以及仅tau蛋白阳性的病理情况。在此,我们报告了对一名携带不同LRRK2突变(Ile1371Val)的意大利PD病例进行的首次神经病理学研究,该病例表现出典型的泛素和α-突触核蛋白阳性的路易体病理。这些发现支持了这样一种观点,即与LRRK2突变相关的神经变性在临床和病理上可能与典型PD无法区分。